Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
2,418 Shares of Amgen Inc. $AMGN Bought by IRON Financial LLC
Barclays Reaffirms Their Buy Rating on Merck & Company (MRK)
Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), Ascendis Pharma (ASND) and Amgen (AMGN)
Amgen announces Phase 3 results of Imdelltra with AstraZeneca's Imfinzi
AstraZeneca announces results from DeLLphi-305 trial of IMFINZI
Teva (TEVA) Gets a Buy from Piper Sandler
1,429 Amgen Inc. $AMGN Shares Sold by Citizens Financial Group Inc. RI - Markets Daily
Amgen Inc. $AMGN Stake Lessened by Atlas Private Wealth Advisors
Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Study
New Amgen drug combination shows survival gains in lung cancer trial
Amgen-AstraZeneca drug combination cut risk of death in small cell lung cancer by 58%
Sterling Capital Management LLC Purchases 22,485 Shares of Amgen Inc. $AMGN
Amgen Reports Combo Cuts Lung Cancer Death Risk 58%
NBT Bank N.A. Acquires New Shares in Amgen Inc. $AMGN
Vision Financial Markets LLC Makes New Investment in Amgen Inc. $AMGN - Stock Observer
AbbVie's Dividend Survived Humira's Patent Cliff. Will Merck and Amgen's?
Forget Chasing 7% Yields: These 5 Dividend Stocks Offer Something Different
14,670 Amgen Inc. $AMGN Shares Sold by Investment House LLC
Amgen Inc. $AMGN Shares Purchased by Brookstone Capital Management
Amgen Inc. $AMGN Shares Sold by Axxcess Wealth Management LLC
Amgen Inc. (NASDAQ:AMGN) Stock Has Consensus Price Target of $387.93 According to Analysts - Stock Observer
Amgen Inc. $AMGN Shares Sold by Investment House LLC - Daily Political
Bispecific dual T cell agonist invikafusp alfa in solid tumors: the phase 1/2 START-001 trial
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial
Amgen (NASDAQ:AMGN) Sets New 1-Year High - Should You Buy? - Markets Daily
Amgen (NASDAQ:AMGN) Sets New 1-Year High - Should You Buy?
Amgen Inc. $AMGN Shares Sold by Foster Victor Wealth Advisors LLC
35,730 Amgen Inc. $AMGN Shares Acquired by Crossmark Global Holdings Inc.
Latin America's Quiet Rise: Argentina and Brazil Enter the Biosimilars Market Spotlight
Multiple myeloma in the Netherlands: 35-year trends in incidence and survival
Amgen (AMGN) Sales Grew 10%, but Can Earnings Catch Up to the Price?
Sawyer & Company Inc Makes New Investment in Amgen Inc. $AMGN
State Street SPDR Dow Jones (DIA) Sells Goldman Sachs and Caterpillar on Monday
Amgen Inc. $AMGN Stock Holdings Raised by Robeco Institutional Asset Management B.V.
Nisa Investment Advisors LLC Purchases 8,294 Shares of Amgen Inc. $AMGN
Biotech Stocks To Keep An Eye On - October 18th - Stock Observer
AstraZeneca and Amgen's Tezspire Achieves 69% Remission in Eosinophilic Esophagitis Trial, ETPharma
2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going)
Dow leads Wall Street higher, investors focus on healthcare stocks
Inhibikase Therapeutics Appoints Scott Wasserman to Board of Directors
Eli Lilly Rises 4% While Foundayo Nears European Approval; Amgen and Novo Nordisk Edge Higher
AstraZeneca & Amgen's Tezspire Meets Phase 3 Endpoints In Eosinophilic Esophagitis
AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial
Amgen Inc. $AMGN Stock Bought by Sumitomo Mitsui DS Asset Management Company Ltd
TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS
Wall Street Zen Upgrades Amgen (NASDAQ:AMGN) to Buy - Markets Daily
10,773 Amgen Inc. $AMGN Shares Sold by Novem Group
5,750 Shares of Amgen Inc. $AMGN Bought by Greg Jennings LLC - Markets Daily
Merck vs. Amgen: Which Dividend Stock Pays You More in 10 Years?
Greg Jennings LLC Buys New Position in Amgen Inc. $AMGN - Stock Observer
Amgen Has the Drugs and the Dividend. Now It Needs the Growth
Mattel Appoints Peter Griffith As Chief Financial Officer
2,560 Amgen Inc. $AMGN Shares Sold by Generali Investments Management Co LLC
Amgen Inc. $AMGN Stock Sold by First Bank & Trust
What State Street SPDR Dow Jones (DIA) Bought: Goldman Sachs Leads on Thursday
Comparing Incyte (NASDAQ:INCY) and Amgen (NASDAQ:AMGN) - Stock Observer
Neuroendocrine Carcinoma Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight | ABNewswire
Amgen (NASDAQ:AMGN) Stock Rating Raised to Buy at Wall Street Zen - Daily Political
Investment Analysts' Upgrades for October 18th (AGX, AMGN, AUGO, AVBP, CG, CNM, CVLT, GDS, GLND, HWBK) - Stock Observer
Amgen Inc. $AMGN Position Lifted by IFP Advisors Inc
Amgen Inc. $AMGN Stock: Frank Rimerman Advisors LLC Raises Holdings
Amgen Inc. (NASDAQ:AMGN) Stock Has Average Price Target of $387.93
Amgen (NASDAQ:AMGN) Upgraded at Wall Street Zen
Amgen Inc. $AMGN Stock Sold by TD Waterhouse Canada Inc. - Daily Political
Amgen Inc. $AMGN Shares Purchased by New England Research & Management Inc. - Zolmax
Amgen Inc. $AMGN Stock Purchased by New England Research & Management Inc.
90,613 Amgen Inc. $AMGN Shares Sold by Fort Washington Investment Advisors Inc. OH
Amgen Inc. $AMGN Shares Acquired by Annex Advisory Services LLC
Amgen (AMGN) Nears Earnings, Is The Stock Pricey?
SPDR Dow Jones Industrial Average ETF (DIA) Sells $31.3 Million More Goldman Sachs on Oct. 14
Amgen Inc. $AMGN Stock Position Reduced by Milestone Asset Management LLC
3,280 Shares of Amgen Inc. $AMGN Bought by Triasima Portfolio Management inc. - Markets Daily
Amgen Inc. $AMGN Stock Holdings Cut by Curated Wealth Partners LLC
Assenagon Asset Management S.A. Acquires 1,344,010 Shares of Amgen Inc. $AMGN
Triasima Portfolio Management inc. Purchases 3,280 Shares of Amgen Inc. $AMGN - Stock Observer
Amgen Inc. $AMGN Stock Sold by Milestone Asset Management LLC - Daily Political
Amgen Inc. $AMGN Stock: Curated Wealth Partners LLC Decreases Holdings - Daily Political
Atherosclerotic Cardiovascular Disease Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight | ABNewswire
Amgen Inc. $AMGN Stake Boosted by State of Alaska Department of Revenue - Zolmax
Amgen Inc. $AMGN Stock Acquired by State of Alaska Department of Revenue
Amgen Inc. $AMGN Stock Sold by WealthPlan Investment Management LLC
Amgen Inc. $AMGN Position Lowered by WealthPlan Investment Management LLC - Zolmax
AMGN vs. MRK: Which Pharma Giant's Dividend Actually Has Room to Grow - 24/7 Wall St.
1,319 Amgen Inc. $AMGN Shares Sold by Godsey & Gibb Inc. - Daily Political
Sanders Morris Harris LLC Makes New Investment in Amgen Inc. $AMGN
Amgen (AMGN) Gains Attention On Aging Treatments, Is The Upside Already Priced In?
Thurston Springer Miller Herd & Titak Inc. Sells 2,027 Shares of Amgen Inc. $AMGN - Stock Observer
How to Turn $500,000 Into a Lazy $16,500 Yearly Passive Income Stream
First Citizens Bank & Trust Co. Purchases 6,611 Shares of Amgen Inc. $AMGN
Top Biotech Stocks To Research - October 14th - Stock Observer
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
